The Maudsley Prescribing Guidelines in Psychiatry (eBook)
1024 Seiten
Wiley-Blackwell (Verlag)
978-1-394-23877-4 (ISBN)
The most up-to-date edition of the gold-standard handbook on the safe and effective prescribing of psychotropic agents
Prescribing medications that treat mental illness is a challenging but essential component of clinical practice. Successful treatment outcomes require careful drug choice and dosage, and other considerations can also have an important impact on patient experiences and long-term care.
In the newly revised fifteenth edition of The Maudsley Prescribing Guidelines in Psychiatry, you will find up-to-date and authoritative guidance on prescribing psychotropic medications to patients. It is an indispensable evidence-based handbook that will continue to serve a new generation of clinicians and trainees.
The book includes analyses of all psychotropic drugs currently used in the United States, the United Kingdom, Canada, Australia, New Zealand, and Japan. It also contains detailed discussions of common and uncommon adverse effects, the ramifications of switching medications, special patient groups, and other clinically relevant subjects. A fully updated reference list closes out each section, as well.
The Maudsley Prescribing Guidelines in Psychiatry is perfect for trainees seeking essential and accurate information on the rational, safe, and effective use of medications for patients with mental illness. Practising clinicians will also benefit from the included guidance on complex issues that might arise less frequently.
David M. Taylor is Director of Pharmacy and Pathology at the Maudsley Hospital and Professor of Psychopharmacology at King's College, London.
Thomas R. E. Barnes Emeritus Professor of Clinical Psychiatry at Imperial College London and joint head of the Prescribing Observatory for Mental Health at the Royal College of Psychiatrists' Centre for Quality Improvement, London, UK.
Allan H. Young Chair of Mood Disorders and Director of the Centre for Affective Disorders in the Department of Psychological Medicine in the Institute of Psychiatry, Psychology and Neuroscience at King's College, London, UK.
List of abbreviations
5HT3 | 5‐hydroxytryptamine 3 |
22q11.2DS | 22q11.2 deletion syndrome |
%w/v | percentage weight per volume |
AACAP | American Academy of Child and Adolescent Psychiatry |
ACE | angiotensin‐converting enzyme |
Ach | acetylcholine |
AChE | acetylcholinesterase |
AChE‐I | acetylcholinesterase inhibitors |
ACOG | American College of Obstetricians and Gynecologists |
AD | Alzheimer’s disease |
ADAPT | Adolescent Depression Antidepressants and Psychotherapy Trial |
ADAS‐cog | Alzheimer’s Disease Assessment Scale – cognitive subscale |
ADH | alcohol dehydrogenase |
ADHD | attention deficit hyperactivity disorder |
ADIS | Anxiety Disorders Interview Schedule |
ADL | activities of daily living |
ADR | adverse drug reactions |
AEC | Anticholinergic Effect on Cognition Scale |
AF | atrial fibrillation |
AIDS | acquired immune deficiency syndrome |
ALAI | aripiprazole long‐acting injection |
ALP | alkaline phosphate |
ALT | alanine aminotransferase |
AMPA | alpha‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid |
AN | anorexia nervosa |
ANC | absolute neutrophil count |
ANI | asymptomatic neurocognitive impairment |
APP | amyloid precursor protein |
ARIA | amyloid‐related imaging abnormality |
ART | antiretroviral therapy |
ASD | autism spectrum disorder |
AST | aspartate aminotransferase |
ATPase | adenosine triphosphatase |
AUD | alcohol use disorder |
AUDIT | Alcohol Use Disorders Identification Test |
Aβ | beta amyloid |
BAC | blood alcohol concentration |
BAP | British Association for Psychopharmacology |
BBB | blood–brain barrier |
bd | twice a day |
BDD | body dysmorphic disorder |
BDNF | brain‐derived neurotrophic factor |
BED | binge eating disorder |
BEN | benign ethnic neutropenia |
BMI | body mass index |
BN | bulimia nervosa |
BNF | British National Formulary |
BP | blood pressure |
BPD | Borderline personality disorder |
BPSD | behavioural and psychological symptoms of dementia |
BuChE | butyrylcholinesterase |
CAMS | Childhood Anxiety Multimodal Study |
CATIE | Clinical Antipsychosis Trials of Intervention Effectiveness |
CBT | cognitive behavioural therapy |
CDRS | Children’s Depression Rating Scale |
CDR‐SB | Clinical Dementia Rating Scale – Sums of Boxes |
CDRS‐R | Children’s Depression Rating Scale‐Revised |
CGAS | Children’s Global Assessment Scale |
CGI | Clinical Global Impression |
CI | confidence interval |
CIBIC‐plus | Clinician’s Interview‐Based Impression of Change plus caregiver input |
CIGH | clozapine‐induced GI hypomotility |
CIWA‐Ar | Clinical Institute Withdrawal Assessment of Alcohol Scale Revised |
CK | creatine kinase |
CKD | chronic kidney disease |
CKD‐EPI | Chronic Kidney Disease Epidemiology Collaboration |
CNS | central nervous system |
COCP | combined oral contraceptive pill |
COMT | catechol‐O‐methyltransferase |
COPD | chronic obstructive pulmonary disease |
COWS | Clinical Opiate Withdrawal Scale |
CQC | Care Quality Commission |
CrCl | creatinine clearance |
CRLTA | clozapine‐related life‐threatening agranulocytosis |
CRP | C‐reactive protein |
CTO | Community Treatment Order |
CUtLASS | Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study |
CVD | cardiovascular disease |
CY‐BOCS | Children’s Yale‐Brown Obsessive Compulsive Scale |
CYP | cytochrome P450 |
DAI | Drug Attitude Inventory |
DBM | dibenzoylmethane |
DBT | dialectical behaviour therapy |
DEXA | dual‐energy x‐ray absorptiometry |
DHA | docosahexaenoic acid |
DHEA | dehydroepiandrosterone |
DIVA‐5 | Diagnostic Interview for ADHD in Adults |
DLB | dementia with Lewy bodies |
DMDD | disruptive mood dysregulation disorder |
DMq | dextromethorphan and low‐dose quinidine |
DOACs | direct‐acting oral anticoagulants |
DoLS | Deprivation of Liberty Safeguards |
DSM‐5 | Diagnostic and Statistical Manual of Mental Disorders, 5th edition |
DVLA | Driver and Vehicle Licensing Agency |
ECG | electrocardiogram |
ECT | electroconvulsive therapy |
EEG | electroencephalogram |
eGFR | estimated glomerular filtration rate |
EMDR | eye movement desensitisation and reprocessing |
EOSS | early‐onset schizophrenia spectrum |
EPA | eicosapentaenoic acid |
EPS | extrapyramidal symptoms |
EPSE | extrapyramidal side effect |
ER | extended release |
ERK | extracellular signal‐regulated kinase |
ES | effect size |
EU | European Union |
FBC | full blood count |
FDA | Food and Drug Administration |
FGA | first‐generation antipsychotic |
FPG | fasting plasma glucose |
FRAMES | feedback, responsibility, |
principles | advice, menu, empathy, self‐efficacy |
FSH | follicle‐stimulating hormone |
FTI | Fatal Toxicity Index |
GABA | gamma‐aminobutyric acid |
GAD | generalised anxiety disorder |
GASS | Glasgow Antipsychotic Side‐effect Scale |
GBL | gamma‐butyrolactone |
G‐CSF | granulocyte colony‐stimulating factor |
GERD | gastro‐esophageal reflux disease |
GFR | glomerular filtration rate |
GGT | gamma‐glutamyl... |
Erscheint lt. Verlag | 20.3.2025 |
---|---|
Reihe/Serie | The Maudsley Prescribing Guidelines Series |
Sprache | englisch |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Psychiatrie / Psychotherapie |
Schlagworte | Adverse drug effects • Drug choice • maximum dose • minimum dose • prescribing for special patient groups • psychotropic drug • switching medication |
ISBN-10 | 1-394-23877-0 / 1394238770 |
ISBN-13 | 978-1-394-23877-4 / 9781394238774 |
Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
Haben Sie eine Frage zum Produkt? |

Größe: 7,3 MB
Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belletristik und Sachbüchern. Der Fließtext wird dynamisch an die Display- und Schriftgröße angepasst. Auch für mobile Lesegeräte ist EPUB daher gut geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.